Head-to-head · WeighScore
Luma Health Co vs ShedRx
The verdict
ShedRx takes it — 87/100 to 74.8/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread on the board — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Luma Health Co | ShedRx |
|---|---|---|
| WeighScore | 74.8/100 | 87/100 |
| Grade | C | B+ |
| Scorecard rank | #62 | #3 |
| Semaglutide | $120/mo (plus a separate fee, compounded) | $199/mo |
| Tirzepatide | $180/mo (compounded) | $299/mo |
| Coverage | 30 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #62 · C
Strengths
- Transparent, competitive pricing published up front — compounded semaglutide from $120/mo, tirzepatide from $180/mo, retatrutide from $170/mo
- No subscription, monthly fee or membership — a direct-to-patient model where you pay per medication, and follow-up visits are free
- Free initial consults for first responders, law enforcement, military, nurses and teachers ($0), and $25 for other healthcare workers
- Founded and led by a named family nurse practitioner (Tiffani McKnight, FNP-C) licensed across 30 states/DC, with HIPAA-compliant virtual visits
- HSA/FSA funds and financing accepted, with itemized invoices for HSA/FSA submission
Where it loses points
- Offers compounded retatrutide (labeled "RTT/GLP-3"), an investigational triple agonist not FDA-approved — a higher-risk, less-studied option
- Compounded medications only — no brand-name Wegovy, Zepbound or Ozempic — and compounded GLP-1s aren't FDA-reviewed or approved
- No LegitScript certification shown and no compounding-pharmacy partner named, so the dispensing pharmacy can't be independently verified
- Small, newly established founder-led practice with a thin website and limited public track record or third-party reviews
- Medication prices are "starting at" and billed on top of a one-time consult fee, so the true first-month cost runs higher than the headline
Graded #3 · B+
Strengths
- Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
- Brand Zepbound and Wegovy available beside the compounded line
- Health coaching included with membership, plus a published 120-day weight-loss guarantee
Where it loses points
- The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- The dispensing compounding pharmacy is not publicly named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.